- Home
- CLDI vs UTSI Comparison
CLDI vs UTSI Comparison
Compare CLDI & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- UTSI
- Stock Information
- Founded
- CLDI 2014
- UTSI 1991
- Country
- CLDI United States
- UTSI China
- Employees
- CLDI N/A
- UTSI N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- UTSI Telecommunications Equipment
- Sector
- CLDI Health Care
- UTSI Telecommunications
- Exchange
- CLDI Nasdaq
- UTSI Nasdaq
- Market Cap
- CLDI 22.3M
- UTSI 25.9M
- IPO Year
- CLDI N/A
- UTSI 2000
- Fundamental
- Price
- CLDI $0.58
- UTSI $2.40
- Analyst Decision
- CLDI Strong Buy
- UTSI
- Analyst Count
- CLDI 2
- UTSI 0
- Target Price
- CLDI $15.00
- UTSI N/A
- AVG Volume (30 Days)
- CLDI 366.6K
- UTSI 2.3K
- Earning Date
- CLDI 05-13-2025
- UTSI 04-11-2025
- Dividend Yield
- CLDI N/A
- UTSI N/A
- EPS Growth
- CLDI N/A
- UTSI N/A
- EPS
- CLDI N/A
- UTSI N/A
- Revenue
- CLDI N/A
- UTSI $10,878,000.00
- Revenue This Year
- CLDI N/A
- UTSI N/A
- Revenue Next Year
- CLDI N/A
- UTSI N/A
- P/E Ratio
- CLDI N/A
- UTSI N/A
- Revenue Growth
- CLDI N/A
- UTSI N/A
- 52 Week Low
- CLDI $0.53
- UTSI $2.20
- 52 Week High
- CLDI $8.30
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- CLDI 33.04
- UTSI 45.95
- Support Level
- CLDI $0.53
- UTSI $2.39
- Resistance Level
- CLDI $0.79
- UTSI $2.50
- Average True Range (ATR)
- CLDI 0.06
- UTSI 0.03
- MACD
- CLDI -0.01
- UTSI 0.01
- Stochastic Oscillator
- CLDI 14.57
- UTSI 50.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.